首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Investigation of Antidiabetic, Antihyperlipidemic, andIn VivoAntioxidant Properties ofSphaeranthus indicusLinn. in Type 1 Diabetic Rats: An Identification of Possible Biomarkers
【24h】

Investigation of Antidiabetic, Antihyperlipidemic, andIn VivoAntioxidant Properties ofSphaeranthus indicusLinn. in Type 1 Diabetic Rats: An Identification of Possible Biomarkers

机译:pha树抗糖尿病,降血脂和体内抗氧化特性的研究。 1型糖尿病大鼠中的代谢:可能的生物标志物的鉴定。

获取原文
           

摘要

The present investigation was aimed to study the antidiabetic, antihyperlipidemic, andin vivoantioxidant properties of the root ofSphaeranthus indicusLinn. in streptozotocin- (STZ-) induced type 1 diabetic rats. Administration of ethanolic extract ofSphaeranthus indicusroot (EESIR) 100 and 200 mg/kg to the STZ-induced diabetic rats showed significant (P<.01) reduction in blood glucose and increase in body weight compared to diabetic control rats. Both the doses of EESIR-treated diabetic rats showed significant (P<.01) alteration in elevated lipid profile levels than diabetic control rats. The EESIR treatment in diabetic rats produced significant increase in superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and decrease in thiobarbituric acid reactive substances (TBARS) levels than diabetic control rats. Administration of EESIR 200 mg/kg produced significant (P<.01) higher antioxidant activity than EESIR 100 mg/kg. The high performance liquid chromatography (HPLC) analysis of EESIR revealed the presence of biomarkers gallic acid and quercetin. In conclusion, EESIR possess antidiabetic, antihyperlipidemic, andin vivoantioxidant activity in type 1 diabetic rats. Its antioxidant and lipid lowering effect will help to prevent diabetic complications, and these actions are possibly due to presence of above biomarkers.
机译:本研究旨在研究印度study草根的抗糖尿病,降血脂和体内抗氧化特性。在链脲佐菌素(STZ-)诱导的1型糖尿病大鼠中。与糖尿病对照大鼠相比,对STZ诱导的糖尿病大鼠施用100和200μmg/ kg的印度千寿菊乙醇提取物(EESIR),显示血糖显着降低(P <.01),体重增加。与糖尿病对照大鼠相比,两种剂量的EESIR治疗的糖尿病大鼠在升高的脂质分布水平上均表现出显着(P <.01)改变。与糖尿病对照组相比,糖尿病大鼠的EESIR治疗使超氧化物歧化酶(SOD),过氧化氢酶(CAT),谷胱甘肽过氧化物酶(GPx)显着增加,硫代巴比妥酸反应性物质(TBARS)降低。与100μg/ kg的EESIR相比,施用200μg/ kg的EESIR产生的抗氧化活性明显更高(P <.01)。 EESIR的高效液相色谱(HPLC)分析表明存在生物标志物没食子酸和槲皮素。总之,EESIR在1型糖尿病大鼠中具有抗糖尿病,抗高血脂和体内抗氧化的活性。它的抗氧化剂和脂质降低作用将有助于预防糖尿病并发症,这些作用可能是由于上述生物标志物的存在所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号